Literature DB >> 12530013

Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin.

Marina E Tsara1, Achilleas D Theocharis, Dimitrios A Theocharis.   

Abstract

This study indicated that human normal rectum (HNR) and human rectum carcinoma (HRC) contained three populations of proteoglycans (PGs). About 63% of the HNR PGs, in terms of uronic acid, were heparan sulfate proteoglycans (HSPGs) of M(r) 500,000 with HS side-chains of M(r) 35,000. The other two populations were versican (29%) and decorin (8%) of M(r) 715,000 and 90,000, respectively, bearing mainly dermatan sulfate (DS) (73%) and chondroitin sulfate (CS) (27%) chains of M(r) 24-26,000 and 20-22,000, respectively. In contrast, in terms of uronic acid, HRC contained 2-fold amounts of PGs. The majority of these PGs (87%) were versican and decorin of lower hydrodynamic size (500,000 and 70,000, respectively) than in HNR, with CS as prominent GAG (70%) in both types of PG. The M(r) of CS and DS chains in these PGs was 12-14,000 and 14-16,000, respectively. The remaining portion (13%) of PG was HSPGs of lower hydrodynamic size (300,000) with smaller HS chains (29,000) than HSPGs of HNR. Moreover, the molar concentrations of versican and decorin estimated from PG-derived protein contents represented a significant, but disproportionate increase, about 5-fold and 8-fold, respectively. The sulfation pattern of rectum carcinoma-associated versican and decorin was significantly altered mainly in containing (62%) 6-sulfated disaccharides and a significant proportion (10%) of non-sulfated disaccharides. DS chains of the tumor-associated versican and decorin contained decreased amounts of iduronic acid. On the metabolic level, the abnormally high production of versican and decorin in this malignant tumor suggests a dramatic modification in their biosynthetic steps at both translational and posttranslational levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12530013

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Age-related differences in human skin proteoglycans.

Authors:  David A Carrino; Anthony Calabro; Aniq B Darr; Maria T Dours-Zimmermann; John D Sandy; Dieter R Zimmermann; J Michael Sorrell; Vincent C Hascall; Arnold I Caplan
Journal:  Glycobiology       Date:  2010-10-14       Impact factor: 4.313

Review 2.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

Review 3.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

Review 4.  Intratumoral drug delivery with nanoparticulate carriers.

Authors:  Hillary Holback; Yoon Yeo
Journal:  Pharm Res       Date:  2011-01-07       Impact factor: 4.200

5.  Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas.

Authors:  Spyros S Skandalis; Vassiliki T Labropoulou; Panagiota Ravazoula; Eleni Likaki-Karatza; Katalin Dobra; Haralabos P Kalofonos; Nikos K Karamanos; Achilleas D Theocharis
Journal:  BMC Cancer       Date:  2011-07-26       Impact factor: 4.430

6.  ADAMTS expression in colorectal cancer.

Authors:  Serafula Filou; Aggeliki Korpetinou; Dora Kyriakopoulou; Dimitrios Bounias; Michael Stavropoulos; Panagiota Ravazoula; Dionysios J Papachristou; Achilleas D Theocharis; Demitrios H Vynios
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 7.  The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer.

Authors:  Adam Pudełko; Grzegorz Wisowski; Krystyna Olczyk; Ewa Maria Koźma
Journal:  FEBS J       Date:  2019-02-05       Impact factor: 5.542

Review 8.  The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.

Authors:  Angela Cho; Viive M Howell; Emily K Colvin
Journal:  Front Oncol       Date:  2015-11-02       Impact factor: 6.244

9.  Comprehensive analysis reveals CTHRC1, SERPINE1, VCAN and UPK1B as the novel prognostic markers in gastric cancer.

Authors:  Zhipeng Zhu; Jiuhua Xu; Lulu Li; Weipeng Ye; Borong Chen; Junjie Zeng; Zhengjie Huang
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.